Study of SNIPR001 for stem cell transplant patients
Part of Infections clinical trials.
This trial tests an oral treatment called SNIPR001 that targets a type of E. coli bacteria resistant to common antibiotics. It may help prevent infections during stem cell transplant recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer, such as leukemia or lymphoma.
- You are scheduled for a stem cell transplant using donor cells.
- You will be taking an antibiotic called levofloxacin (which is a type of fluoroquinolone) to prevent infections.
- You carry a specific bacteria called fluoroquinolone-resistant E. coli in your gut (this will be checked with a swab).
- You agree to use effective birth control if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
This trial tests an injectable drug called SPN01 to see if it is safe and how the body handles it. It includes healthy volunteers and people with colorectal cancer who are scheduled for surgery.
This study looks at a specific type of bacteria in the gut of patients who have had a stem cell transplant. It aims to understand how these bacteria affect the risk of infection, which could help improve care for future patients.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
This trial tests whether a special virus (bacteriophage) that attacks E. coli bacteria can help control bacteria in the bladder without causing an infection. It's for people with spinal cord injury who use a catheter and have E. coli in their urine but no active infection.
This trial tests a new injection called CEL001 for people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. The goal is to see if it is safe and find the right dose.
Hear when a new E Coli Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.